November 2026 Session: Clinical AI Governance in an Evolving Landscape: A National Overview-Clinical AI Governance in an Evolving Landscape: A National Overview

Video Transcription

Video Summary

Allison Kim of the American Gastroenterological Association moderated a CMSS webinar on clinical AI governance, featuring Dr. Andrew Wong of the University of Utah. Wong reviewed AI’s growing influence on society and healthcare, including rapid adoption by physicians and patients, emerging diagnostic capabilities, and direct-to-consumer health products.<br /><br />He discussed evidence suggesting AI can perform well in clinical diagnosis and support primary care, while cautioning that results are not always reliable. Risks include harmful advice, privacy and security concerns, bias, environmental costs, over-reliance, and loss of skills among trainees.<br /><br />Wong emphasized that healthcare organizations should not assume vendor claims are sufficient: AI tools need evaluation for accuracy and bias, ideally through benchmarking, external validation, and ongoing monitoring after deployment. Effective governance requires multidisciplinary expertise, institutional resources, and attention to fairness, transparency, trustworthiness, and accountability.<br /><br />In discussion, participants explored patient trust, regulation, payer involvement, and how professional societies can prepare clinicians. Wong advised societies to promote AI literacy while emphasizing critical thinking and the ability to apply knowledge in practice. He expects incremental near-term gains, particularly in documentation, but believes broader adoption will depend on demonstrating safety and value, addressing costs, and earning public trust.

Keywords

clinical AI governance

Allison Kim

American Gastroenterological Association

Dr. Andrew Wong

University of Utah

AI in healthcare

benchmarking and validation

patient trust

AI literacy